Assay efficiency was determined using a seven-point standard curve from 20 copies to 20 million copies. Ideally, the efficiency equals 100%, representing a perfect doubling of template at every cycle. Typically, good assay efficiencies range between 90-110%. R 2 represents the linearity of the standard curve and how well the standard curve data points fit the linear regression line. Acceptable values are > 0.98. cDNA Cq is the Cq value obtained from 25 ng of cDNA transcribed from universal RNA when performing wet-lab validation of the assay. cDNA Tm is the melting temperature of the amplicon when running a melt curve analysis. gDNA Cq is the Cq value obtained when running the assay with 2.5 ng of genomic DNA, a more than moderate level of genomic DNA contamination. The specificity is represented by the percentage of specific amplicon reads as measured by next generation sequencing (NGS).
IFN-γ and an even stronger upregulation after stimulation with TNF-α, while the 2 cytokines combined led to the highest level of both ICAM-1 and VCAM-1 mRNA expression. No difference was found for L1CAM mRNA expression levels. ICAM-2 expression was significantly downregulated upon treatment with TNF-α and IFN-γ, albeit no change in its expression was found upon treatment with each of the proinflammatory cytokines separately. Following treatment of the BBB with IFN-γ and TNF-α combined, mRNA expression levels of the tight junction molecules occludin, TJP-1 and claudin were significantly decreased. Although less pronounced, the cytokines separately also induced a marked reduction in the expression levels of mRNA encoding tight junction proteins. Results are expressed as fold regulation compared to steady-state BBB co-cultures (n=3, ** p<0.01). 
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